FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384202235> ?p ?o ?g. }

• W4384202235 endingPage "1534" @default.
• W4384202235 startingPage "1534" @default.
• W4384202235 abstract "We evaluated neutralizing antibodies against the Omicron variant and Anti-Spike IgG response in solid organ (SOT) or hematopoietic stem cell (HSTC) recipients after a third dose of BNT162b2 (BNT) or CoronaVac (CV) following two doses of CV. In total, 95 participants underwent SOT (n = 62; 44 liver, 18 kidney) or HSCT (n = 27; 5 allogeneic, 22 autologous) were included from five centers in Turkey. The median time between third doses and serum sampling was 154 days (range between 15 to 381). The vaccine-induced antibody responses of both neutralizing antibodies and Anti-Spike IgGs were assessed by plaque neutralizing assay and immunoassay, respectively. Neutralizing antibody and Anti-Spike IgG levels were significantly higher in transplant patients receiving BNT compared to those receiving CV (Geometric mean (GMT):26.76 vs. 10.89; p = 0.03 and 2116 Au/mL vs. 172.1 Au/mL; p < 0.001). Solid organ transplantation recipients, particularly liver transplant recipients, showed lower antibody levels than HSCT recipients. Thus, among HSCT recipients, the GMT after BNT was 91.29 and it was 15.81 in the SOT group (p < 0.001). In SOT, antibody levels after BNT in kidney transplantation recipients were significantly higher than those in liver transplantation recipients (GMT: 48.32 vs. 11.72) (p < 0.001). Moreover, the neutralizing antibody levels after CV were very low (GMT: 10.81) in kidney transplantation recipients and below the detection limit (<10) in liver transplant recipients. This study highlights the superiority of BNT responses against Omicron as a third dose among transplant recipients after two doses of CV. The lack of neutralizing antibodies against Omicron after CV in liver transplant recipients should be taken into consideration, particularly in countries where inactivated vaccines are available in addition to mRNA vaccines." @default.
• W4384202235 created "2023-07-14" @default.
• W4384202235 creator A5001746955 @default.
• W4384202235 creator A5008202344 @default.
• W4384202235 creator A5011357671 @default.
• W4384202235 creator A5019583546 @default.
• W4384202235 creator A5020878414 @default.
• W4384202235 creator A5022317430 @default.
• W4384202235 creator A5022490135 @default.
• W4384202235 creator A5024266896 @default.
• W4384202235 creator A5025758246 @default.
• W4384202235 creator A5040731801 @default.
• W4384202235 creator A5040853291 @default.
• W4384202235 creator A5046347011 @default.
• W4384202235 creator A5050749656 @default.
• W4384202235 creator A5056979219 @default.
• W4384202235 creator A5067781646 @default.
• W4384202235 creator A5072911008 @default.
• W4384202235 creator A5074849840 @default.
• W4384202235 creator A5076831881 @default.
• W4384202235 creator A5084373096 @default.
• W4384202235 creator A5088762344 @default.
• W4384202235 creator A5088971047 @default.
• W4384202235 date "2023-07-12" @default.
• W4384202235 modified "2023-10-18" @default.
• W4384202235 title "BNT162b2 or CoronaVac as the Third Dose against Omicron: Neutralizing Antibody Responses among Transplant Recipients Who Had Received Two Doses of CoronaVac" @default.
• W4384202235 cites W3102328262 @default.
• W4384202235 cites W3158103490 @default.
• W4384202235 cites W3178010802 @default.
• W4384202235 cites W3183904285 @default.
• W4384202235 cites W3184115715 @default.
• W4384202235 cites W3196336490 @default.
• W4384202235 cites W3197746999 @default.
• W4384202235 cites W3206807960 @default.
• W4384202235 cites W3208594704 @default.
• W4384202235 cites W3209139070 @default.
• W4384202235 cites W3212101057 @default.
• W4384202235 cites W4200198452 @default.
• W4384202235 cites W4206675538 @default.
• W4384202235 cites W4214646636 @default.
• W4384202235 cites W4214754463 @default.
• W4384202235 cites W4220955692 @default.
• W4384202235 cites W4224230335 @default.
• W4384202235 cites W4225125062 @default.
• W4384202235 cites W4226377603 @default.
• W4384202235 cites W4281939105 @default.
• W4384202235 cites W4282975475 @default.
• W4384202235 cites W4290723708 @default.
• W4384202235 cites W4297026254 @default.
• W4384202235 cites W4318218985 @default.
• W4384202235 doi "https://doi.org/10.3390/v15071534" @default.
• W4384202235 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37515220" @default.
• W4384202235 hasPublicationYear "2023" @default.
• W4384202235 type Work @default.
• W4384202235 citedByCount "0" @default.
• W4384202235 crossrefType "journal-article" @default.
• W4384202235 hasAuthorship W4384202235A5001746955 @default.
• W4384202235 hasAuthorship W4384202235A5008202344 @default.
• W4384202235 hasAuthorship W4384202235A5011357671 @default.
• W4384202235 hasAuthorship W4384202235A5019583546 @default.
• W4384202235 hasAuthorship W4384202235A5020878414 @default.
• W4384202235 hasAuthorship W4384202235A5022317430 @default.
• W4384202235 hasAuthorship W4384202235A5022490135 @default.
• W4384202235 hasAuthorship W4384202235A5024266896 @default.
• W4384202235 hasAuthorship W4384202235A5025758246 @default.
• W4384202235 hasAuthorship W4384202235A5040731801 @default.
• W4384202235 hasAuthorship W4384202235A5040853291 @default.
• W4384202235 hasAuthorship W4384202235A5046347011 @default.
• W4384202235 hasAuthorship W4384202235A5050749656 @default.
• W4384202235 hasAuthorship W4384202235A5056979219 @default.
• W4384202235 hasAuthorship W4384202235A5067781646 @default.
• W4384202235 hasAuthorship W4384202235A5072911008 @default.
• W4384202235 hasAuthorship W4384202235A5074849840 @default.
• W4384202235 hasAuthorship W4384202235A5076831881 @default.
• W4384202235 hasAuthorship W4384202235A5084373096 @default.
• W4384202235 hasAuthorship W4384202235A5088762344 @default.
• W4384202235 hasAuthorship W4384202235A5088971047 @default.
• W4384202235 hasBestOaLocation W43842022351 @default.
• W4384202235 hasConcept C126322002 @default.
• W4384202235 hasConcept C159654299 @default.
• W4384202235 hasConcept C203014093 @default.
• W4384202235 hasConcept C2777408962 @default.
• W4384202235 hasConcept C2779261636 @default.
• W4384202235 hasConcept C2779609443 @default.
• W4384202235 hasConcept C2780303639 @default.
• W4384202235 hasConcept C2911091166 @default.
• W4384202235 hasConcept C71924100 @default.
• W4384202235 hasConcept C90924648 @default.
• W4384202235 hasConceptScore W4384202235C126322002 @default.
• W4384202235 hasConceptScore W4384202235C159654299 @default.
• W4384202235 hasConceptScore W4384202235C203014093 @default.
• W4384202235 hasConceptScore W4384202235C2777408962 @default.
• W4384202235 hasConceptScore W4384202235C2779261636 @default.
• W4384202235 hasConceptScore W4384202235C2779609443 @default.
• W4384202235 hasConceptScore W4384202235C2780303639 @default.
• W4384202235 hasConceptScore W4384202235C2911091166 @default.
• W4384202235 hasConceptScore W4384202235C71924100 @default.
• W4384202235 hasConceptScore W4384202235C90924648 @default.

• next